Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
International Journal of Molecular Sciences|January 10, 2026
A Computational Approach for the Prediction of p53 and BCL-2 Protein-Protein InteractionsColette Creamer, Victoria Neely, Hisashi HaradaBiorxiv : the Preprint Server for Biology|February 20, 2025
Proteasome Inhibition Enhances Lysosome-mediated Targeted Protein DegradationAhmed M Elshazly, Nayyerehalsadat Hosseini, Shanwei Shen, et al.British Journal of Cancer|December 15, 2025
Targeting Bcl-xL to eliminate chemotherapy-induced tumor dormancy and prevent breast cancer metastasisKinjal Gupta, Nicholas Koelsch, Victoria Neely, et al.International Journal of Molecular Sciences|September 9, 2023
Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer TreatmentVictoria Neely, Alekhya Manchikalapudi, Khanh Nguyen, et al.International Journal of Molecular Sciences|November 9, 2024
A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to ChemotherapyMelanie M Sinanian, Afshan Rahman, Ahmed M Elshazly, et al.Cell Death & Disease|May 11, 2026
Proteasome inhibition enhances lysosome-mediated targeted protein degradationAhmed M Elshazly, Nayyerehalsadat Hosseini, Janakiram Vangala, et al.Cancers|August 26, 2023
BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast CancerAhmed M Elshazly, Melanie M Sinanian, Victoria Neely, et al.Scientific Reports|September 23, 2023
NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapySofian Al Shboul, Mohammed El-Sadoni, Ahmad Alhesa, et al.Cancer Research Communications|September 20, 2024
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial ApoptosisKranthi Kumar Chougoni, Victoria Neely, Boxiao Ding, et al.Pageof 1